Precigen's (PGEN) "Overweight" Rating Reaffirmed at Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Precigen (NASDAQ:PGEN) Announces Earnings Results dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Iridian Asset Management LLC CT Sells 73,286 Shares of Precigen, Inc. (NASDAQ:PGEN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Precigen (NASDAQ:PGEN) Upgraded at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Precigen (NASDAQ:PGEN) Stock Rating Reaffirmed by JMP Securities themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, […]
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]
Magnolia Capital Advisors LLC purchased a new stake in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other large investors have also recently bought and […]
Magnolia Capital Advisors LLC purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other hedge funds also recently added to or reduced their stakes in the company. Emfo LLC […]